decaro

NMTR: an explosive biotech microcap

NASDAQ:NMTR   None
NMTR had an incredible run over the past month. But it appears that it has been rejected at resistance, and will retrace fib levels back toward $1.00 before exiting this wedge.

A defined risk strategy here is to buy the $1.00 puts, continue rolling them out, and then within the next month add the $1 calls to form a long straddle. Be careful as liquidity is low.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。